---
title: Test-Retest Reliability in DETECT
nct_id: NCT01733641
overall_status: TERMINATED
sponsor: Emory University
study_type: OBSERVATIONAL
primary_condition: Reliability Properties of a Concussion Screening Tool
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01733641.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01733641"
ct_last_update_post_date: 2014-12-12
last_seen_at: "2026-05-12T07:06:41.314Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Test-Retest Reliability in DETECT

**Official Title:** Test-Retest Psychometrics of a Novel Neuropsychological Assessment Tool: Reliability Measures for DETECT

**NCT ID:** [NCT01733641](https://clinicaltrials.gov/study/NCT01733641)

## Key Facts

- **Status:** TERMINATED
- **Why Stopped:** Limited eligible sample size for study outcomes
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 44
- **Lead Sponsor:** Emory University
- **Conditions:** Reliability Properties of a Concussion Screening Tool
- **Start Date:** 2011-09
- **Completion Date:** 2013-04
- **CT.gov Last Update:** 2014-12-12

## Brief Summary

Healthy volunteers without concussion, currently participating in non-or-limited contact sports teams at Emory University will undergo Display Enhanced Testing for Concussion and mild traumatic brain injury (mTBI) (DETECT) on three separate days: at baseline, day 50, and day 90. Prior to enrollment participants will be allocated to the test-retest arm or the exercise arm.

## Eligibility

- **Minimum age:** 16 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* age \> or = 16
* eligible for active participation during the National Collegiate Athletic Association (NCAA) season or member of the 2011 - 2012 or 2012-2013 club team
* Participation in a non or minimal contact sport

Exclusion Criteria:

* \< age 16
* history of concussion in the previous 6 months
* any of the following: learning disabilities, attention deficient disorder, attention deficit hyperactivity disorder, depression or other psychiatric disorder, sleep apnea, seizure disorder, migraine headaches, previous central nervous system (CNS) surgery
* chronic drug or alcohol use; or drug or alcohol use with the previous 24 hours
* inability to complete the study protocol (90 days)
```

## Primary Outcomes

- **Primary Objective is to assess the reliability of the DETECT cognitive assessment tool, as measured by changes in DETECT scores from baseline in non-injured athletes.** _(time frame: 90 days)_ — Subjects will complete the DETECT cognitive assessment tool at Baseline, 50 days, and 90 days.

## Locations (1)

- Emory University, Atlanta, Georgia, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.emory university|atlanta|georgia|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01733641.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01733641*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*